Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Acne mRNA

Vaccine (mRNA vaccine) · Immune activation · developed by Sanofi Pasteur, a Sanofi Company

Phase 1/2 Most advanced trial
SNY Developer
1 Registered trials

What is Acne mRNA?

Acne mRNA is an mRNA vaccine, a vaccine platform that delivers messenger RNA to induce an immune response. It is studied in acne vulgaris.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Vaccine (mRNA vaccine)
Mechanism
Immune activation
Therapy area
Dermatology
Developer
Sanofi Pasteur, a Sanofi Company (SNY)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1/2

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT07756957 Phase 1/2 Acne Recruiting SNY

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Acne

More from Sanofi Pasteur, a Sanofi Company

Follow SNY, the company behind Acne mRNA

See SNY's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

SNY catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.